FDA to weigh test of blood substitute out of public view.
作者信息
Burton Thomas
出版信息
Wall St J (East Ed). 2006 Jul 11:D3.
PMID:16906688
Abstract
摘要
相似文献
1
FDA to weigh test of blood substitute out of public view.
Wall St J (East Ed). 2006 Jul 11:D3.
2
FDA to weigh using fake blood in trauma trial.
Wall St J (East Ed). 2006 Jul 6:B1, B2.
3
Blood-substitute study is criticized by U.S. agency.
Wall St J (East Ed). 2006 Mar 10:A3.
4
No-consent trials raise concern.
Nat Med. 1999 Mar;5(3):250-1. doi: 10.1038/6442.
5
Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver.
IRB. 2006 Mar-Apr;28(2):16-9.
6
Use of substitution for blood draws ethics challenge.
Wall St J (East Ed). 2006 Mar 20:A2.
7
Light, fast, and flexible: a new approach to regulation of human gene therapy.
McGeorge Law Rev. 2000 Fall;32(1):261-87.
8
31st Bethesda Conference. Emergency Cardiac Care. Task force 3: Special aspects of research conduct in the emergency setting: Waiver of informed consent.
J Am Coll Cardiol. 2000 Mar 15;35(4):862-80.
9
Artificial-blood study has critics seeing red.
Chron High Educ. 2006 Jun 16;52(41):A17.
10
Fitting a square peg into a round hole?: imposing informed consent and post-trial obligations on United States sponsored clinical trials in developing countries.
South Calif Interdiscip Law J. 2002 Spring;11(2):339-60.
Zotero 插件